UNAIDS urges speed and compassion urging pharmaceutical companies to enable access to new, life-saving medicines DAVOS/GENEVA, 21 January 2025—Today, at the World Economic Forum’s annual meeting in ...

It’s all the more tragic because HIV drugs can keep people from catching the virus, and prevent those living with the virus from passing it on. If everyone who needed these drugs could access them, ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...

AbbVie and Gilead are going back to their roots and leaning on their established areas of expertise to set themselves up for ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Our medical tools and techniques are rapidly improving but our system for delivering health care is a source of widespread ...

Grinsztejn is the first Latin American to head the IAS, which has been advocating since the 1980s for science-based HIV policies ... which evaluated the efficacy of [the drug] lenacapavir for ...

A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice yearly investigational pre-exposure prophylaxis (PrEP) injection.

(MENAFN- Caribbean News Global) GENEVA, Switzerland – WHO is convening a Guideline Development Group (GDG) for the development of new guidelines on the use of injectable lenacapavir as pre ...

For almost a century, Science News journalists have covered advances in science, medicine and technology for the general public, including the 1925 Scopes “monkey” trial, the advent of the ...